- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Bortezomib or observation
Total 19979 results
-
NanoAlvandCompletedMultiple Myeloma, Refractory
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Janssen-Cilag G.m.b.HCompletedMultiple MyelomaGermany
-
M.D. Anderson Cancer CenterCompletedMultiple MyelomaUnited States
-
Groupe Francophone des MyelodysplasiesUnknownMyelodysplastic SyndromesFrance
-
University Hospital HeidelbergGerman Cancer Research Center; Janssen-Cilag International NV; inVentiv Health... and other collaboratorsCompleted
-
California Cancer ConsortiumNational Cancer Institute (NCI)TerminatedGastric CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Milton S. Hershey Medical CenterUnknownMantle Cell LymphomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedMelanoma | Solid Tumor | Brain and Central Nervous System TumorsUnited States
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)CompletedBreast Cancer | Head and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Melanoma (Skin)United States
-
University of NottinghamUniversity of Wisconsin, MadisonCompletedStroke | Pneumonia | Acute Coronary Syndrome
-
Masonic Cancer Center, University of MinnesotaMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.TerminatedLeukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Neuroblastoma | WilmsTumorUnited States
-
Alexandria UniversityCompleted
-
The First Affiliated Hospital with Nanjing Medical...CompletedStroke | Atrial Fibrillation | Systemic EmbolismChina
-
Medical University InnsbruckCompletedPain | Fracture | Bone Density
-
National Cancer Institute (NCI)Terminated
-
Rasim GucalpMillennium Pharmaceuticals, Inc.TerminatedNon-small Cell Lung CancerUnited States
-
European Myeloma NetworkFondazione EMN Italy OnlusCompleted
-
E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd.Recruiting
-
HK inno.N CorporationUnknownHealthyKorea, Republic of
-
Duke UniversitySpectrum Pharmaceuticals, IncTerminated
-
National Cancer Institute (NCI)TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
GlaxoSmithKlineWithdrawn
-
Arthrosi TherapeuticsCompletedHealthy VolunteersAustralia
-
AHS Cancer Control AlbertaAbbott; Tom Baker Cancer CentreCompleted
-
Dana-Farber Cancer InstituteMillennium Pharmaceuticals, Inc.CompletedChronic Graft Versus Host DiseaseUnited States
-
Jazz PharmaceuticalsRecruitingPregnancy | Pregnancy Complication | Maternal Complications | Birth Outcomes, AdverseUnited States
-
Hospital General de MexicoRecruitingAcute Lymphoblastic Leukemia, in Relapse | Chemotherapeutic Toxicity | Minimal Residual DiseaseMexico
-
Shahid Beheshti University of Medical SciencesRecruitingAntibody-mediated RejectionIran, Islamic Republic of
-
Beijing Chao Yang HospitalEnrolling by invitationMultiple Myeloma | BortezomibChina
-
University of Michigan Rogel Cancer CenterCompletedLymphoma, Non-Hodgkin | Hodgkin's LymphomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...CompletedGraft-versus-Host DiseaseUnited States
-
PETHEMA FoundationCompleted
-
Biotronik SE & Co. KGCompleted
-
Stichting Hemato-Oncologie voor Volwassenen NederlandEuropean Myeloma Network; Gruppo Italiano Malattie EMatologiche dell'Adulto; DSMM... and other collaboratorsActive, not recruitingMultiple MyelomaSweden, Norway, Italy, Netherlands, Belgium, Switzerland, Australia, Denmark, Finland, Czechia, Turkey, Austria, Luxembourg, Hungary, Greece, Portugal
-
Hanmi Pharmaceutical Company LimitedCompletedOsteoporosisKorea, Republic of
-
University of Southern DenmarkDanish Cancer SocietyCompletedColorectal Cancer
-
Chinese University of Hong KongTerminated
-
Bastyr UniversityRecruiting
-
Christian RuffNot yet recruitingBehavior and Behavior Mechanisms
-
SCRI Development Innovations, LLCNovartisTerminated
-
University of ChicagoNational Cancer Institute (NCI)Completed
-
Imperial College LondonAstraZeneca; Cancer Research UKCompleted
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)TerminatedStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
CephalonCompletedMultiple MyelomaUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States